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Introduction
▼
The human gut is colonised by a plethora of 
microorganisms, which have the potential to 
promote either beneficial or harmful effects on 
gastrointestinal integrity, function, and overall 
health [18, 22, 30]. In the attempt to protect the 
internal body environment, the intestinal epithe­
lial lining plays a crucial role in preventing harm­
ful microorganisms, some of which present 
pathogenic properties (e. g., gram negative endo­
toxins, such as lipopolysaccharides), from enter­
ing portal and systemic circulation [25, 27]. 
Prolonged physical exertion however has previ­
ously been shown to disturb intestinal epithelial 
integrity, resulting in increased epithelial per­
meability, endotoxin leakage, and a subsequent 
cytokine-mediated systemic inflammatory res-
ponse similar to that of an acute infectious epi­
sode [5, 6, 11, 25].
Most recently, research investigating circulatory 
endotoxin and cytokine profile during a 230 km 
multi­stage ultra­marathon in hot ambient condi­
tions (32–40 °C), observed a modest circulatory 
endotoxaemia at rest (60 pg · ml − 1 average increase) 
and after each stage completion (30 pg · ml − 1 aver­
age increase), accompanied by amplified pro-
inflammatory cytokine responses throughout 
competition (rest: IL-6 152 %, IL-1β 95 %, TNFα 
168 %, and IFNγ 102 %; and pre- to post-stage: 
IL-6 238 %, IL-1β 64 %, TNFα 101 %, and IFNγ 39 %), 
despite overnight recovery between stages [11]. 
Interestingly, the pro-inflammatory cytokine 
responses appeared to be counteracted by a com­
pensatory anti-inflammatory cytokine cascade 
(rest: IL-10 1 271 % and IL-1ra 106 %; and pre- to 
post­stage: IL­10 1 100 % and IL­1ra 207 %). These 
findings support the proposition that performing 
physical exertion in hot ambient conditions 
poses a greater threat to gastrointestinal integ­
rity and function, leading to enhanced intestinal 
endotoxin permeability and episodes of clinical 
significance with fatal outcomes being reported 
(i. e., heat stroke and systemic inflammatory 
response syndrome) in military, occupation and 
sport populations [1, 23, 32, 36, 43, 60, 62]. This is 
accepted after revision  
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Abstract
▼
The study aimed to determine circulatory endo­
toxin concentration, cytokine profile, and gastro­
intestinal symptoms of ultra­endurance runners 
(UER, n = 17) in response to a 24­h continuous 
ultra­marathon competition (total distance 
range: 122–208 km) conducted in temperate 
ambient conditions (0–20 °C) in mountainous 
terrain. Body mass and body temperature were 
measured, and venous blood samples were taken 
before and immediately after competition. Sam­
ples were analysed for gram­negative bacterial 
endotoxin, C-reactive protein, cytokine profile, 
and plasma osmolality. Gastrointestinal symp­
toms were also monitored throughout competi­
tion. Mean exercise­induced body mass loss was 
(mean ± SD) 1.7 ± 1.8 % in UER. Pre­ and post­ 
competition plasma osmolality in UER was 
286 ± 11 mOsmol · kg − 1 and 286 ± 9 mOsmol · kg − 1, 
respectively. Pre­ to post­competition increases 
(p < 0.05) were observed for endotoxin (37 %), 
C-reactive protein (2 832 %), IL-6 (3 436 %), IL-1β 
(332 %), TNF-α (35 %), IL-10 (511 %), and IL-8 
(239 %) concentrations in UER, with no change in 
the control group (CON; n = 12) observed 
(p > 0.05). Gastrointestinal symptoms were 
reported by 75 % of UER, with no symptoms 
reported by CON. IL-10 (r = 0.535) and IL-8 
(r = 0.503) were positively correlated with gastro­
intestinal symptoms. A 24­h continuous ultra­
marathon competition in temperate ambient 
conditions resulted in a circulatory endotoxae­
mia and pro-inflammatory cytokinaemia, coun­
teracted by a compensatory anti-inflammatory 
response.
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not surprising taking into account that exertional­heat stress 
has the potential to exacerbate splanchnic hypoperfusion and 
ischemia more than exertional stress in thermoneutral environ­
ments [58, 61], and thus induce greater disturbances to gastroin­
testinal integrity and cytokine profile. Indeed, previous 
laboratory controlled studies have consistently observed greater 
cytokine responses (e. g., IL-6, TNFα, IL-1ra, and IL-10) in hot 
(32–39 °C) conditions, compared with more temperate (15–
22 °C) conditions [8, 39, 46, 52, 54]; but the degree of impact 
from intestinal originated endotoxins was not confirmed. Such 
observations indicate that heat stress appears to play a role in 
the degree of systemic cytokinaemia observed after physical 
exertion. Moreover, systemic endotoxin and cytokine responses 
have also been associated with symptomatic manifestations of 
gastrointestinal distress [24, 25, 60] commonly associated with 
prolonged exposure to exertional and exertional­heat stress 
[37, 40, 42, 45].
Even though exercising in hot ambient temperatures per se 
appears to disturb intestinal integrity, promote endotoxin leak­
age, and augment cytokine-mediated inflammatory responses, it 
is plausible that extreme ultra­endurance competition, in the 
absence of heat­stress, but with prolonged exposure to a multi­
tude of other stressors (e. g., prolonged physical exertion, sleep 
disturbances, compromised hydration and (or) nutritional sta­
tus) [12, 13], may also have the potential to impact gastrointesti­
nal integrity, as well as the subsequent cytokine­mediated 
inflammatory cascade in a similarly negative manner. For exam­
ple, increased splanchnic jarring associated with physical exer­
tion, especially prolonged periods of running, has been shown to 
induce a greater intestinal burden and injury due to mechanical 
trauma [44, 45]. Whereas a pronounced cytokine (i. e., IL­6 and 
somnogenic cytokines IL-1β, TNFα, and IFNγ) profile is com­
monly seen after acute periods of sleep deprivation [15, 51] and 
compromised energy (especially carbohydrate energy) status 
[33, 47].
From a practical perspective, single- and multi-stage ultra-
endurance events have increased in popularity over the past 
decade, yet research into the physiological demands and 
immune responses to such an extreme sport is limited [31]. 
Therefore, to date, the short and long-term effects of such ultra-
endurance exposure on gastrointestinal integrity and immune 
responses have not yet been established. It is plausible that 
ultra­endurance runners competing in such extreme events are 
potentially a high­risk population group for pronounced acute 
and long­term gastrointestinal and immune dysfunction, lead­
ing to the development of clinically and (or) sub­clinically sig­
nificant episodes, including gastrointestinal symptoms, 
gastrointestinal diseases, chronic systemic inflammation, auto­
immune diseases, chronic fatigue and underperformance syn­
drome [7, 29, 47, 50]. With this in mind, the aims of the current 
study were to determine circulatory endotoxin concentration 
and cytokine profile of ultra-endurance runners in response to a 
24­h continuous ultra­marathon competition conducted in tem­
perate ambient conditions; and additionally to determine the 
relationship between these responses with gastrointestinal 
symptoms. Taking into account the nature of the event, it was 
hypothesised that a pronounced circulatory endotoxaemia 
would be seen after the event, and a pro-inflammatory cytoki­
naemic response would mirror the endotoxaemia. Additionally, 
it was hypothesised that correlations between circulatory 
responses and gastrointestinal symptoms would be seen.
Methods
▼
Setting and participants
The study was conducted during the 2011 and 2012 Glenmore24 
Trail Race (www.glenmore24.com), held during the first week of 
September, in the Cairngorms National Park, Scottish Highlands, 
UK (ambient temperature range: 0–20 °C, relative humidity 
range: 54–82 %). The 24­h continuous ultra­marathon was con­
ducted on a 6 km looped-course on a variety of terrains; includ­
ing off-road trails, paths, and grassland. Distance covered by 
participants ranged between 122 km to 208 km at an estimated 
average intensity of 7.0 ± 1.3 METs (SenseWear 7.0, Bodymedia, 
PA, Pittsburgh, USA), and in an altitude averaging 342 m above 
sea level. After ethical approval from the Coventry University 
Ethics Committee that conforms with the 2008 Helsinki Declara­
tion for Human Research Ethics and ethical standards of the 
International Journal of Sports Medicine [21], a convenience 
sampling observational cohort was studied, whereby 25 out of 
48 ultra­endurance runners (UER) entering the event volun­
teered to participate in the study; however, complete blood sam­
pling and biomarker data were only achieved in n = 17 (male 
n = 14, female n = 3: age 40 ± 7 years, height 177 ± 9 cm, body mass 
78.1 ± 11.9 kg). Additionally, 17 individuals who did not compete 
(absence of exercise stress), but were present at the race loca­
tion, volunteered to participate in the study as part of the con­
trol (CON) group for comparative purposes, however complete 
blood sampling and biomarker data were only achieved in n = 12 
(male n = 4, female n = 8: age 30 ± 12 years, height 169 ± 10 cm, 
body mass 68 ± 13 kg). All participants reported no illness and 
(or) infection in the 12­weeks leading up to the ultra­marathon. 
Additionally, no anti-inflammatory agents of any form were 
consumed by all participants in the week leading up and during 
competition.
Study design and data collection
Within the hour prior to commencement of competition (11:00 h 
to 12:00 h), body mass was determined using calibrated elec­
tronic scales (BF510, Omron Healthcare, Ukyo-ku, Kyoto, Japan) 
placed on a hard levelled surface. Participants were then 
required to sit in an upright position for 10 min before tympanic 
temperature (Ttymp; Braun Thermoscan, Kronberg, Germany) 
was determined and whole blood collected for all participants 
(UER and CON). Whole blood samples were collected by 
venepuncture without venostasis from an antecubital vein using 
a 21G butterfly syringe into one lithium heparin (6 ml, 
1.5 IU · ml − 1 heparin; Becton Dickinson, Oxford, UK) and one 
K3EDTA (6 ml, 1.6 mg · ml − 1 of ethylenediaminetetraacetic acid; 
Becton Dickinson, Oxford, UK) vacutainer tube. Body mass was 
re­measured in those participants who needed to urinate prior 
to the start of competition. Immediately after competition 
(12:00 h the following day) and before any foods or fluids could 
be consumed, body mass and Ttymp were measured, followed 
immediately by blood sampling, identical to pre­competition 
procedures. Additionally, within the hour after competition, 
trained dietetic researchers conducted a standardised struc­
tured interview on participants to ascertain total foods and flu­
ids ingested during the ultra­marathon, as previously reported 
[12, 13]. Severe gastrointestinal symptoms [42] were also 
explored at this time through a research­generated symptomol­
ogy tool by trained researchers.
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Dietary analysis and hydration status
Total energy and water intake through foods and fluids were 
determined and analysed through Dietplan 6 dietary analysis 
software (v6.60, Forestfield Software, Horsham, West Sussex, 
UK). A comprehensive description of the dietary assessment and 
analysis technique used can be viewed in Costa et al. [10]. Energy 
expenditure was measured by a triaxial accelerometer, which 
also included measurements of heat flux, skin temperature and 
galvanic skin responses (SenseWear 7.0, Bodymedia, PA, Pitts­
burgh, USA), as has been used previously to aid in nutritional 
intervention during a mountain­based multi­stage ultra­mara­
thon [4]. Pre­ and post­competition plasma osmolality (POsmol) 
was determined from 50 μl lithium heparin plasma samples in 
duplicate by freezepoint osmometry (Osmomat 030, Gonotec, 
Germany), as recommended previously [53]. The coefficient of 
variation (CV) for POsmol was 3.5 %.
Blood sample collection and analysis
Blood samples were immediately centrifuged and plasma ali­
quoted into eppendorfs and stored frozen initially at  − 20 °C dur­
ing the ultra­marathon competition, prior to transferring 
to  − 80 °C storage after completion of the experimental proce­
dure. Whole blood (lithium heparin) haemoglobin concentra­
tion and haematocrit were used to estimate changes in plasma 
volume relative to pre-competition, as previously reported [9]. 
All blood parameters were corrected for changes in plasma vol­
ume. Circulatory concentrations of C­reactive protein (CRP) 
(eBioscience, Hatfield, UK), IL-6, TNF-α, IL-1β, IFN-γ, IL-10, and 
IL-8 (human pro-inflammatory 7-plex ultra-sensitive kit 
(K15008C­1), MesoDiscovery, Gaithersburg, MD, USA) were 
determined by ELISA using K3EDTA plasma as per manufactur­
er’s instructions. Gram­negative bacterial endotoxin concentra­
tion was determined by limulus amebocyte lysate (LAL) 
chromogenic endpoint assay using K3EDTA plasma (HIT302, 
Hycult Biotech, Uden, Netherlands) as per manufacturer’s 
instructions. In short, 20 μl of sample was diluted in 380 μl of 
endotoxin­free water, and then incubated at 75 °C for 10 min. 
Once at room temperature, 50 μl of standards, blank, positive 
control, and samples were added to plate wells in duplicate. To 
enhance assay validity, background plate reading without LAL 
reagent was performed at OD 405 nm. 50 µl LAL reagent was 
then added. Plate was covered and incubated at 22 °C for 30 min, 
followed by reading at OD 405 nm. Concentration was calculated 
by plotting the absorbance against standards in a linear regres­
sion curve and eliminating background error. The assay was per­
formed using endotoxin­free and dypryogenated consumables 
in a sterile laboratory. All plasma variables analysed were indi­
vidually run on the same day, with standards and controls on 
each plate, and each participant assayed on the same plate. The 
intra-assay coefficient of variation for plasma variables analysed 
was  ≤ 14.7 %.
Data analysis
Data in text are presented as mean ± standard deviation (SD), 
otherwise specified. For clarity, data in figures are presented as 
mean ± standard error of the mean (SEM). Due to the commonly 
large individual variation in cytokine responses [55], data in 
tables are presented as mean and 95 % confidence interval (CI) 
for mean (lower and upper boundary). Data were processed and 
analysed in SPSS for Windows (SPSS v.17.0.2, Illinois, US). Prior 
to data analysis, outlying values for all variables were detected 
through box­plot analysis and appropriately removed. Diagnos­
tic checks (Shapiro­Wilks test of normality and Levene’s homo­
geneity of variance test) were performed prior to analysis. 
Where data violated the assumption of normality, data were log 
transformed, and the transformed data were analysed using 
parametric statistics, verified against non-parametric equiva­
lents where appropriate. Paired­sample t­tests were applied to 
determine pre- to post-competition variable differences; while 
independent­sample t­tests were applied for group compari­
sons (UER vs. CON, and distance covered ( < 160 km vs.  ≥ 160 km)) 
[38, 41]. Due to insufficient female ultra-endurance runners 
sample size, statistical analysis was not viable on this occasion, 
Spearman’s rank correlation analysis was used to assess associa­
tions between blood­borne variables with perceived gastroin­
testinal symptoms. Individual participant ratios between IL-1β 
and TNF-α with IL-10 were calculated to determine the pro- to 
anti-inflammatory cytokine balance. Descriptive statistics were 
used to explore severe gastrointestinal symptoms. The accept­
ance level of significance was set at p < 0.05.
Results
▼
Energy balance and hydration status
Total energy intake and energy expenditure over the 24­h period 
was 21 ± 12 and 53 ± 11 MJ for UER, and 12.4 ± 1.3 and 13.6 ± 4.9 MJ 
for CON, respectively. Significant body mass loss occurred pre- to 
post­competition (p = 0.001) in UER (pre­competition: 78.1 ± 
11.9 kg, post-competition: 76.8 ± 12.0 kg, 1.7 ± 1.8 %). No signifi­
cant difference in POsmol was observed pre­ to post­competition 
in UER (pre­competition: 286 ± 11 mOsmol · kg − 1, post­competi­
tion: 286 ± 9 mOsmol · kg − 1) and remained within normal clini­
cal reference range [59]. Compared with CON, POsmol pre­ and 
post­competition was lower in UER (p = 0.05 and p < 0.001, 
respectively).
Tympanic temperature
Tympanic temperature (Ttymp) was within normal range pre­ and 
post-stage (36.0–37.5 °C) in UER and CON, with no difference 
between pre­ and post­stage Ttymp observed in both groups. No 
difference in Ttymp was observed between UER and CON.
Circulatory gram-negative bacterial endotoxin 
concentration
A pre­ to post­competition increase in circulatory endotoxin 
concentration (overall mean change: 37 %) was observed in UER 
(p = 0.009;  ●▶	 Fig. 1), with no significant change in CON evident 
(p = 0.005 vs. UER). No difference in circulatory endotoxin con­
centration was observed for distance covered.
Plasma C-reactive protein concentration
A pre­ to post­competition increase in plasma CRP concentra­
tion (2 832 %) was observed in UER (p < 0.001;  ●▶	 Fig. 2), with no 
significant change in CON evident (p < 0.001 vs. UER). No differ­
ence in plasma CRP concentration was observed for distance 
covered.
Plasma interleukin-6 concentration
A pre­ to post­competition increase in plasma IL­6 concentra­
tion (3 436 %) was observed in UER (p < 0.001;  ●▶	 Table 1), with no 
significant change in CON evident (p < 0.001 vs. UER). Post-com­
petition plasma IL­6 concentration was higher (p = 0.018) in UER 
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UER totalling a distance ≥ 160 km compared to UER totalling a 
distance < 160 km ( ●▶	 Table 2).
Plasma interleukin-8 concentration
A pre­ to post­competition increase in plasma IL­8 concentra­
tion (239 %) was observed in UER (p < 0.001;  ●▶	 Table 1), with no 
significant change in CON evident (p < 0.001 vs. UER). A trend 
(p = 0.102) for higher post­competition plasma IL­8 concentra­
tion was observed in UER totalling a distance ≥ 160 km compared 
to UER totalling a distance < 160 km ( ●▶	 Table 2).
Pro-inflammatory to anti-inflammatory cytokine ratio
A pre- to post-competition decrease in TNF-α:IL-10 ratio (72 %; 
p < 0.001) was observed in UER, with no significant change in 
CON evident (p = 0.011 vs. UER). While a 32 % decrease in 
IL-1β:IL-10 ratio was also observed in UER (p = 0.063 vs. CON), 
but this failed to reach significance (p > 0.05). Post-competition 
TNF-α:IL-10 ratios were substantially lower (p = 0.008) in UER 
totalling a distance ≥ 160 km compared to UER totalling a dis­
tance < 160 km.
Gastrointestinal symptoms
Severe gastrointestinal symptoms were a common feature 
amongst the cohort sampled for endotoxin and cytokine 
responses; with 75 % of the cohort reporting at least one severe 
gastrointestinal symptom (including 63 % reporting nausea) dur­
ing competition. Greater reports of severe gastrointestinal 
symptoms were reported by UER totalling a distance  ≥ 160 km 
compared to UER totalling a distance < 160 km (p = 0.012). Spear­
man’s rank correlation analysis showed a positive correlation 
between reported rates of gastrointestinal symptoms and 
plasma IL­10 (r = 0.535, p = 0.034) and IL­8 (r = 0.503, p = 0.047) 
concentrations.
totalling a distance ≥ 160 km compared to UER totalling a dis­
tance < 160 km ( ●▶	 Table 2).
Plasma interleukin-1 beta concentration
A pre- to post-competition increase in plasma IL-1β concentra­
tion (332 %) was observed in UER (p = 0.05;  ●▶	 Table 1), with no 
significant change in CON evident (p = 0.032 vs. UER). No differ­
ence in plasma IL-1β concentration was observed for distance 
covered.
Plasma tumor necrosis factor alpha concentration
A pre- to post-competition increase in plasma TNF-α concentra­
tion (35 %) was observed in UER (p < 0.001;  ●▶	 Table 1), with no 
significant change in CON evident. No difference in plasma 
TNF-α concentration was observed for distance covered.
Plasma interferon gamma concentration
No significant change in pre- to post-competition plasma IFN-γ 
concentration was observed in UER or CON. No difference in 
plasma IFN-γ concentration was observed for distance covered.
Plasma interleukin-10 concentration
A pre­ to post­competition increase in plasma IL­10 concentra­
tion (511 %) was observed in UER (p < 0.001;  ●▶	 Table 1), with no 
significant change in CON evident (p < 0.001 vs. UER). Post-com­
petition plasma IL­10 concentration was higher (p = 0.002) in 
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Fig. 1 Circulatory gram-negative bacterial endotoxin concentration 
of ultra-endurance runners (UER) participating in a 24-h continuous 
ultra-marathon. Mean ± SEM: UER (closed squares; n = 17) and CON (open 
squares; n = 12).  *  *  p < 0.01 vs. pre-competition; aa p < 0.01 vs. CON.
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Fig. 2 Plasma C-reactive protein concentration of ultra-endurance run-
ners (UER) participating in a 24-h continuous ultra-marathon. Mean ±  
SEM: UER (closed squares; n = 17) and CON (open squares; n = 12). 
*  * p < 0.01 vs. pre-competition; aa p < 0.01 vs. CON.
Table 1	 Plasma	cytokine	profile	of	ultra-endurance	runners	(UER)	before	
and immediately after a 24-h continuous ultra-marathon competition.
Pre-Competition Post-Competition
Plasma IL-6 concentration (pg · ml	−	1)
UER 0.4 (0.3 to 0.5) 14.5 (9.3 to 19.7) * * aa
CON 0.6 (0.2 to 0.9) 1.8 (0.5 to 3.1)
Plasma	IL-1β	concentration	(pg	·	ml	−	1)
UER 0.1 (0.0 to 0.3) 0.6 (0.1 to 1.1) * a
CON 0.0 (0.0 to 0.1) 0.0 (0.0 to 0.1)
Plasma	TNF-α	concentration	(pg	·	ml	−	1)
UER 2.8 (2.5 to 3.2) 3.8 (3.5 to 4.2) * * 
CON 2.6 (1.8 to 3.3) 3.2 (2.4 to 4.0)
Plasma	IFN-γ	concentration	(pg	·	ml	−	1)
UER 1.0 (0.6 to 1.4) 1.2 (0.3 to 2.2)
CON 1.1 (0.6 to 1.6) 1.1 (0.6 to 1.6)
Plasma IL-10 concentration (pg · ml	−	1)
UER 2.1 (1.3 to 2.9) 12.8 (7.3 to 18.2) * * aa
CON 1.6 (0.1 to 3.2) 1.7 (0.1 to 3.3)
Plasma IL-8 concentration (pg · ml	−	1)
UER 11.4 (9.4 to 13.4) 38.7 (26.3 to 51.1) * * aa
CON 14.0 (10.2 to 17.7) 14.2 (11.1 to 17.2)
Mean and 95 % CI (lower and upper bound): UER (n = 17) and CON (n = 12).  * p < 0.05 
and  * * p < 0.01 vs. pre-competition, ap < 0.05 and aap < 0.01 vs. CON
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Discussion
▼
The current study aimed to determine circulatory endotoxin 
concentration and cytokine profile of runners participating in a 
24-h continuous ultra-marathon competition; and additionally 
to determine the relationship between these responses with 
gastrointestinal symptoms. Findings confirm that in the absence 
of heat­stress, but with prolonged exposure to other multi­
stressors, resultant endotoxaemia with accompanying cytoki­
naemia were characteristic of an acute infectious episode. Severe 
gastrointestinal symptoms were a common feature, with higher 
symptom occurrence associated with greater compensatory 
anti-inflammatory (i. e., IL-10) and immune activation (i. e., IL-8) 
responses. Additionally, post­competition IL­6, IL­10, and IL­8 
responses were higher and TNF-α:IL-10 ratio was lower in those 
ultra-endurance runners totalling a distance ≥ 160 km.
In comparison to a 230 km multi­stage ultra­marathon con­
ducted in hot ambient conditions (32 –40 °C), whereby resting 
plasma CRP concentration increased 889 % and circulatory endo­
toxin concentration peaked at 21 % by Stage 5 [11], plasma CRP 
and circulatory endotoxin concentration in the current study 
were markedly more pronounced despite the absence of heat 
stress, increasing 2 832 % and 37 % post­competition, respec­
tively. These results suggest that amplified CRP concentrations 
likely reflect other multi-factorial influences, such as the degree 
of the exertional stress, sleep deprivation, energy deficit, and 
bacterial endotoxin presence in circulation simultaneously. 
Whereas, the endotoxin leakage was likely induced by distur­
bances to intestinal epithelial integrity (i. e., splanchnic hypoper­
fusion, ischemia, and mechanical trauma), associated with the 
physical exertion volume; despite endotoxin leakage being more 
commonly studied amongst exertional­heat stress protocols 
[2, 3]. Due to practical limitations in monitoring parameters 
after competition (i. e., participant follow­up at race location 
during the acute and prolonged recovery period), the current 
study was not able to determine the recovery time course of CRP. 
However, such responses have been shown to remain elevated 
above pre­exercise values for a considerable period of time (i. e., 
up to 19 days after an Ironman triathlon event) [34].
Despite temperate ambient conditions, the current study 
observed increases in pro-inflammatory cytokine responses 
post-competition, similar to that of an acute infectious episode; 
whereby IL-6, IL-1β, and TNF-α increased 3 436 %, 332 %, and 
35 %, respectively. These results are similar to previous field-
based studies that have observed cytokinaemia during exer­
tional-heat stress [2, 3, 24, 56]. For example, increases in IL-6 
(152 %), IL-1β (95 %), TNF-α (168 %), and IFNγ (102 %) were con­
sistently observed post­stage during a 230 km multi­stage ultra­
marathon conducted in hot ambient conditions [11]. Acute 
pro-inflammatory response is commonly accompanied by com­
pensatory anti-inflammatory (i. e., 511 % increase in IL-10) and 
immune activation (i. e., 239 % increase in IL-8) responses. As 
such, the observed decreases in TNF-α:IL-10 and IL-1β:IL-10 
ratios in the current study suggest that the anti-inflammatory 
properties of IL­10 may have restricted the magnitude of pro­
inflammatory cytokine responses induce by the extreme nature 
of this ultra-marathon. Notably, those ultra-endurance runners 
totalling a distance of  ≥ 160 km had significantly greater post-
competition IL-6 and IL-10 responses (overall mean: 19.8 pg · ml − 1 
and 19.7 pg · ml − 1, respectively) compared to those ultra­endur­
ance runners totalling a distance < 160 km (overall mean: 
8.5 pg · ml − 1 and 4.9 pg · ml − 1, respectively). Additionally, post­
competition TNF-α:IL-10 ratio was substantially lower in ultra-
endurance runners totalling a distance ≥ 160 km compared to 
ultra­endurance runners totalling a distance < 160 km.
Results from the current study suggest that in well­trained indi­
viduals, where the exertional stress is well tolerated, compensa­
tory anti-inflammatory responses may offset potential clinically 
significant episodes associated with profound and prolonged 
cytokine profile disturbance [17, 19, 35, 57], thus acting as a 
safeguard. Indeed, disturbances to cytokine profile have been 
linked to the aetiology of gastrointestinal and autoimmune dis­
eases [7, 16], while the fatigue inducing properties of certain 
cytokines, especially IL-6, have recently been confirmed and 
established [29, 48–50]. Previous research has shown that ill­
ness­prone individuals have an altered cytokine response (i. e., 
pro- to anti-inflammatory balance) after a standardised bout of 
treadmill running compared with healthy runners who have a 
more proportionally regulated cytokine response [14]. There­
fore, it is plausible that in illness­prone individuals partaking in 
prolonged physical exertion who experience impaired cytokine 
regulation (i. e., over-exaggerated cytokine-mediated inflamma­
tory response) not adequately counteracted by anti-inflamma­
tory responses, the resulting cytokine imbalance may potentially 
contributing to pathophysiology [17]. Investigation into the role 
of challenging compensatory anti-inflammatory responses 
through internal (e. g., endotoxin challenge) and external (e. g., 
physical strain) mechanisms is warranted, and may act to 
strengthen tolerance to exertional exposure with or without 
additional stressors (e. g., heat stress, sleep deprivation, and/or 
compromised nutrition) in illness­prone individuals.
Table 2 Pre- and post-competition circulatory gram-negative bacterial 
endotoxin concentration, plasma C-reactive protein concentration, and 
plasma	cytokine	profile	of	ultra-endurance	runners	who	completed		≥	160	km	
and  < 160 km during a 24-h continuous ultra-marathon competition.
Pre-Competition Post-Competition
Circulatory gram-negative bacterial endotoxin concentration (EU · ml	−	1)
	≥	160	km 3.5 (2.7 to 4.3) 4.5 (3.6 to 5.2)
 < 160 km 3.1 (2.5 to 3.7) 4.7 (3.3 to 6.0)
Plasma C-reactive protein concentration (µg · ml	−	1)
	≥	160	km 0.5 (0.2 to 0.8) 22.2 (19.4 to 26.1)
 < 160 km 1.0 (0.0 to 2.1) 23.4 (21.1 to 25.8)
Plasma IL-6 concentration (pg · ml	−	1)
	≥	160	km 0.5 (0.2 to 0.6) 19.8 (12.0 to 30.4) a
 < 160 km 0.4 (0.3 to 0.5) 8.5 (5.6 to 11.5)
Plasma	IL-1β	concentration	(pg	·	ml	−	1)
	≥	160	km 0.3 (0.0 to 0.7) 0.6 (0.0 to 1.6)
 < 160 km 0.0 (0.0 to 0.0) 0.6 (0.0 to 1.4)
Plasma	TNF-α	concentration	(pg	·	ml	−	1)
	≥	160	km 2.7 (1.8 to 3.4) 3.8 (3.3 to 4.4)
 < 160 km 3.0 (2.7 to 3.3) 3.8 (3.2 to 4.5)
Plasma	IFN-γ	concentration	(pg	·	ml	−	1)
	≥	160	km 1.0 (0.3 to 1.5) 1.2 (0.1 to 1.7)
 < 160 km 0.7 (0.2 to 1.1) 0.5 (0.2 to 0.7)
Plasma IL-10 concentration (pg · ml	−	1)
	≥	160	km 2.0 (0.8 to 3.1) 19.7 (10.1 to 27.0) aa
 < 160 km 2.2 (0.7 to 3.7) 4.9 (3.3 to 6.5)
Plasma IL-8 concentration (pg · ml	−	1)
	≥	160	km 11.5 (9.0 to 15.3) 47.7 (24.8 to 76.6) §
 < 160 km 11.3 (8.0 to 14.6) 28.5 (22.3 to 34.8)
Mean	and	95	%	CI	(lower	and	upper	bound):		≥	160	km	(n	=	9)	and		<	160	km	(n	=	8).	
ap < 0.05 and aap < 0.01 vs.  < 160 km, § p = 0.102 vs.  < 160 km
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As previously reported, due to practical limitations, the current 
study was not able to determine the recovery time course of the 
cytokine profile. Previous ultra-endurance studies (e. g., long-
distance triathlon and ultra­marathon running) have however 
observed variations in cytokine recovery. For example, IL-6 and 
TNF-α returned to baseline by 24 h after a 50 km ultra-marathon 
[28]; whilst IL-6 returned to baseline values after 16 h, with no 
significant change observed in TNF-α after a long-distance tri­
athlon [24]. Furthermore, on cessation of 2 endurance events of 
similar duration (i. e., long­distance triathlon and 100 km run­
ning event), IL­6, IL­10, and IL­1ra peaked after competition, 
returning to baseline values 7 days after the events [20]. 
Whereas, after a long distance triathlon, IL­6 remained elevated 
on day 1 (345 %) and day 5 (79 %); while IL-10 was elevated on 
day 1 (37 %), declining by 4 % below pre­competition concentra­
tions on day 5 [34].
Circulatory endotoxin and pro-inflammatory cytokine responses 
seen in the current study have previously been associated with 
symptomatic manifestations of gastrointestinal distress [24–
26, 60]. In accordance with a recent multi­stage ultra­marathon 
study [11], despite 58 % of UER sampled for endotoxin and 
cytokine responses reporting severe gastrointestinal symptoms 
during competition, and reporting being greater in ultra­endur­
ance runners totalling a distance ≥ 160 km compared to ultra-
endurance runners totalling a distance < 160 km, no relationships 
between gastrointestinal symptoms with circulatory endotoxin 
and pro-inflammatory cytokine concentrations were observed 
in the current study. Interestingly, an association between the 
reported number of severe gastrointestinal symptoms and 
plasma concentrations of anti-inflammatory IL-10 (r = 0.535) 
and immune activator IL­8 (r = 0.503) were observed. These 
results suggest that alterations to intestinal motility and 
mechanical trauma (i. e., repetitive jarring) associated with the 
prolonged running period may have promoted intestinal mucosa 
and epithelial disturbance and potential damage [44, 45], induc­
ing gastrointestinal symptoms and stimulating immune 
responses into protection and repair; and not necessarily that 
endotoxaemia and cytokinaemia causes symptoms.
Conclusion
▼
In conclusion, a 24­h continuous ultra­marathon competition 
conducted in temperate ambient conditions with inclusion of 
multi-stressors (i. e., sleep deprivation and energy deficit) 
resulted in endotoxaemia with accompanying cytokinaemia 
characteristic of an acute infectious episode. Gastrointestinal 
symptoms were commonly reported amongst ultra­endurance 
runners, with higher symptom occurrence associated with 
greater compensatory anti-inflammatory responses and 
immune activation suggesting that alterations to intestinal 
motility and mechanical trauma may have promoted intestinal 
mucosa and epithelial disturbance, inducing gastrointestinal 
symptoms. Further research is required to clarify the impact of 
over-exaggerated cytokine-mediated inflammatory responses, 
similar to those observed in the current study, on the potential 
long­term health implications in ‘high­risk’ illness­prone indi­
viduals.
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